青光眼阀植入物治疗难治性青光眼  

The Ahmed Glaucoma Valve Implantation for Refractory Glaucoma

作　　者：杨新光[1] 郑晓龙[1] 潘小凤[1] 王为农[1] 

机构地区：[1]西安市第四军医大学唐都医院眼科,710038

出　　处：《眼科学报》2000年第4期259-261,共3页Eye Science

摘　　要：目的:观察Ahmed青光眼引流植入物治疗难治性青光眼的疗效。方法:采用Ahmed青光眼引流植入物,共治疗28例(29只眼)难治性青光眼,其中新生血管性青光眼10例(10只眼),青少年型青光眼5例(6只眼),其它青光眼13例(13只眼)。结果:术后随访3～12个月,新生血管性青光眼的眼压由术前40.9±7.32mmHg降至20.63±2.75mmHg(1mmHg=0.133kPa);人工晶体联合玻璃体手术后青光眼的眼压由术前41±5.66mmHg降至术后18.00±2.12mmHg;青少年型青光眼的眼压由术前33.65±5.28mmHg降至术后16.45±1.48mmHg;常规滤过性手术失败的青光眼的眼压由术前31.43±4.13mmHg降至18.13±1.25mmHg。术后常见并发症有:浅前房、前房积血、前葡萄膜炎等。结论:Ahmed青光眼引流植入物是治疗难治性青光眼的一种较为有效的降眼压方法。眼科学报2000;16:259～261。Objective: To evaluate the efficacy of the Ahmed Glaucoma Valve implant in the treatment of refractory glaucoma. Methods: 28 cases(29 eyes) of refractory glacucoma were treated by the Ahmed glaucoma Valve implant, including 10 cases (10 eyes) of neovascular glaucoma, 5 cases (6 eyes) of juvenile glaucoma and 13 cases (13 eyes) of other causes glaucoma. Results: Post-operative follow-up time was 3-12 months. The intraocular pressure (IOP) was lowered from preoperative 40. 9±7.32 mmHg (lmmHg = 0. 133kPa) to postoperative 20. 63±?2. 75 mmHg in Neovascular glaucoma; from preoperative 41±5. 66 to postoperative 18. 00±2. 12 mmHg in glaucoma after IOL implant combined with vitrectomy operation; from preoperative 33. 65±5. 28 to postoperative 16. 45±1.48 mmHg in juvenile glaucoma; from preoperative 31. 43±4.13 to postoperative 18. 13±1. 25 mmHg in the failure conventional filtering surgery of glaucoma. The postoperative complicatons were flat anterior chamber, hyphema, anterior iritis and so on. Conclusion: The Ahmed glaucoma valve implant is a useful method in lowing IOP of refractory glaucoma. Eye Science 2000; 16: 259-261.

关 键 词：AHMED青光眼阀 难治性青光眼 眼压 治疗 

分 类 号：R775[医药卫生—眼科]